Brainomix
To add a bio or update company history, please click update information.
News from Brainomix
Brainomix
24 Feb 2026
Brainomix lands a £4.8m Series C extension led by Parkwalk Advisors and Hostplus for AI medical imaging in stroke and lung fibrosis
Brainomix develops medical imaging software that helps clinicians assess stroke and lung fibrosis using automated image analysis. Its platforms support diagnosis and treatment decisions by analysing scans and providing clinical insights at the point of care.
Brainomix
20 Mar 2025
Brainomix completes £14m Series C led by Parkwalk Advisors to advance AI imaging technology in healthcare
Brainomix develops AI-powered medical imaging software for stroke and lung disease, helping clinicians diagnose conditions faster and make better treatment decisions using automated biomarkers.
Brainomix
- Health
- Oxford, United Kingdom
- £18.8m
- brainomix.com
- Update Information
More venture news
- 9 Jul 2026
Leo Cancer CareLeo Cancer Care unlock £50m Series D led by Yu Galaxy for its upright imaging and radiotherapy platform
Series DHealth - 8 Jul 2026
Respiro DiagnosticsRespiro Diagnostics raises a £1m pre-seed round led by Zinc Venture Capital and SFC Capital to develop breath-based liquid biopsy for lung cancer
Pre-seedHealth - 30 Jun 2026Saltroad
Saltroad raises £1.5m in funding led by Techstart Ventures to build an AI-enabled speech and language therapy workforce
EquityHealth